MEDICAGO UNLEASH THE POWER OF PLANTS
Live / Registered — Registered (as of 11 Oct 2022)
What this means for you
Registered since 11 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90620821
- Registration number
- 6868840
- Mark type
- Stylized text
- Filed
- 02 Apr 2021
- Published for opposition
- 26 Jul 2022
- Registered
- 11 Oct 2022
- Attorney of record
- Benjamin M. Cantor
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
- Class 040 — Treatment of materials: Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
- Class 042 — Scientific and technological services: Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
- Class 044 — Medical, beauty and agricultural services: Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
Owner
- Medicago Inc., Québec (Québec), CA
- Medicago Inc., Québec (Québec), CA
- Medicago Inc., Québec (Québec), CA
Prosecution history
- 11 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2022 — PUBLISHED FOR OPPOSITION
- 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 22 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Jun 2022 — EXAMINERS AMENDMENT E-MAILED
- 22 Jun 2022 — EXAMINERS AMENDMENT -WRITTEN
- 02 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jun 2022 — ASSIGNED TO LIE
- 25 May 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Nov 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED